Fund For Hot Korean Biotech Lures Foreign Investors
This article was originally published in PharmAsia News
Executive Summary
In its efforts to support South Korean biotech and healthcare firms to successfully advance into overseas markets, the state-run Small and Medium Business Administration (SMBA) will create a joint fund worth $100 million with a U.S.-based venture capital firm to invest in the booming sector.